Cargando…
The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
BACKGROUND: The cardiovascular risk models and subclinical atherosclerotic indicators are both recommended for cardiovascular risk stratification. The accordance between the incidence of subclinical atherosclerosis and subjects with low and moderate cardiovascular risk is unclear. HYPOTHESIS: Subjec...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577528/ https://www.ncbi.nlm.nih.gov/pubmed/37522647 http://dx.doi.org/10.1002/clc.24087 |
_version_ | 1785121344399081472 |
---|---|
author | Li, Yan Zhang, Yinghua Xiao, Keling Si, Jin Zhang, Haoyu Sun, Lijie Miao, Zupei Zhao, Ting Sun, Jinghao Sun, Xipeng Liu, Zhi Gao, Jing Zhao, Jing Chu, Xi Li, Jing |
author_facet | Li, Yan Zhang, Yinghua Xiao, Keling Si, Jin Zhang, Haoyu Sun, Lijie Miao, Zupei Zhao, Ting Sun, Jinghao Sun, Xipeng Liu, Zhi Gao, Jing Zhao, Jing Chu, Xi Li, Jing |
author_sort | Li, Yan |
collection | PubMed |
description | BACKGROUND: The cardiovascular risk models and subclinical atherosclerotic indicators are both recommended for cardiovascular risk stratification. The accordance between the incidence of subclinical atherosclerosis and subjects with low and moderate cardiovascular risk is unclear. HYPOTHESIS: Subjects with low and moderate cardiovascular risk have a lower incidence of subclinical atherosclerosis compared with subjects with high risk. METHODS: Brachial‐ankle pulse wave velocity (BaPWV) and brachial flow‐mediated dilation (BFMD) were measured in 421 subjects without a history of atherosclerotic cardiovascular disease (ASCVD) from October 2016 to January 2020. All subjects were classified into low, moderate, and high risk based on Framingham and China‐par risk models respectively. RESULTS: Mean age was 57.05 ± 9.35 years and 248 (58.9%) were male. In subjects with low, moderate, and high risk assessed by Framingham and China‐par risk models, the percentage of abnormal BaPWV ( > 1400 cm/s) was 42.9%, 70.1%, 85.7%, and 40.4%, 71.4%, 89.7%, respectively. Meanwhile, the percentage of abnormal BFMD ( ≤ 7%) was 43.8%, 68.5%, 77.3%, and 44.9%,72.1%, and 76.6%. According to Framingham‐based high‐risk categories, positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for BaPWV abnormality were 85.7%, 39.4%, 36.1%, and 87.5%, respectively. For BFMD abnormality, the values were 77.3%, 40.1%, 34.1%, and 81.8%, respectively. According to China‐par high‐risk categories, the values for BaPWV abnormality were 89.7%, 43.8%, 45.6%, and 89.0%, respectively. For BFMD abnormality, the values were 76.6%, 41.3%, 40.7%, and 77%, respectively. In multivariate analysis, age and blood pressure were the independent predictors for subclinical atherosclerosis in subjects with low‐moderate risk. CONCLUSIONS: More than one‐half of subjects with low and moderate risk already have detectable subclinical atherosclerosis, indicating higher cardiovascular risk beyond the traditional stratification. |
format | Online Article Text |
id | pubmed-10577528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105775282023-10-17 The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk Li, Yan Zhang, Yinghua Xiao, Keling Si, Jin Zhang, Haoyu Sun, Lijie Miao, Zupei Zhao, Ting Sun, Jinghao Sun, Xipeng Liu, Zhi Gao, Jing Zhao, Jing Chu, Xi Li, Jing Clin Cardiol Clinical Trial Result BACKGROUND: The cardiovascular risk models and subclinical atherosclerotic indicators are both recommended for cardiovascular risk stratification. The accordance between the incidence of subclinical atherosclerosis and subjects with low and moderate cardiovascular risk is unclear. HYPOTHESIS: Subjects with low and moderate cardiovascular risk have a lower incidence of subclinical atherosclerosis compared with subjects with high risk. METHODS: Brachial‐ankle pulse wave velocity (BaPWV) and brachial flow‐mediated dilation (BFMD) were measured in 421 subjects without a history of atherosclerotic cardiovascular disease (ASCVD) from October 2016 to January 2020. All subjects were classified into low, moderate, and high risk based on Framingham and China‐par risk models respectively. RESULTS: Mean age was 57.05 ± 9.35 years and 248 (58.9%) were male. In subjects with low, moderate, and high risk assessed by Framingham and China‐par risk models, the percentage of abnormal BaPWV ( > 1400 cm/s) was 42.9%, 70.1%, 85.7%, and 40.4%, 71.4%, 89.7%, respectively. Meanwhile, the percentage of abnormal BFMD ( ≤ 7%) was 43.8%, 68.5%, 77.3%, and 44.9%,72.1%, and 76.6%. According to Framingham‐based high‐risk categories, positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for BaPWV abnormality were 85.7%, 39.4%, 36.1%, and 87.5%, respectively. For BFMD abnormality, the values were 77.3%, 40.1%, 34.1%, and 81.8%, respectively. According to China‐par high‐risk categories, the values for BaPWV abnormality were 89.7%, 43.8%, 45.6%, and 89.0%, respectively. For BFMD abnormality, the values were 76.6%, 41.3%, 40.7%, and 77%, respectively. In multivariate analysis, age and blood pressure were the independent predictors for subclinical atherosclerosis in subjects with low‐moderate risk. CONCLUSIONS: More than one‐half of subjects with low and moderate risk already have detectable subclinical atherosclerosis, indicating higher cardiovascular risk beyond the traditional stratification. John Wiley and Sons Inc. 2023-07-31 /pmc/articles/PMC10577528/ /pubmed/37522647 http://dx.doi.org/10.1002/clc.24087 Text en © 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Trial Result Li, Yan Zhang, Yinghua Xiao, Keling Si, Jin Zhang, Haoyu Sun, Lijie Miao, Zupei Zhao, Ting Sun, Jinghao Sun, Xipeng Liu, Zhi Gao, Jing Zhao, Jing Chu, Xi Li, Jing The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
title | The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
title_full | The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
title_fullStr | The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
title_full_unstemmed | The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
title_short | The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
title_sort | incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk |
topic | Clinical Trial Result |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577528/ https://www.ncbi.nlm.nih.gov/pubmed/37522647 http://dx.doi.org/10.1002/clc.24087 |
work_keys_str_mv | AT liyan theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhangyinghua theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT xiaokeling theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sijin theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhanghaoyu theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sunlijie theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT miaozupei theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhaoting theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sunjinghao theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sunxipeng theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT liuzhi theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT gaojing theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhaojing theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT chuxi theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT lijing theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT liyan incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhangyinghua incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT xiaokeling incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sijin incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhanghaoyu incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sunlijie incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT miaozupei incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhaoting incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sunjinghao incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT sunxipeng incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT liuzhi incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT gaojing incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT zhaojing incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT chuxi incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk AT lijing incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk |